Literature DB >> 4562175

Immunosuppression and malignancy.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4562175      PMCID: PMC1788691     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

1.  Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression.

Authors:  E A Lipsmeyer
Journal:  Arthritis Rheum       Date:  1972 Mar-Apr

2.  De-novo brain tumours in renal-transplant recipients.

Authors:  S A Schneck; I Penn
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

3.  Immmunosuppressive drugs in the treatment of autoimmune haemolytic anaemia.

Authors:  S M Worlledge; M C Brain; A C Cooper; J R Hobbs; J V Dacie
Journal:  Proc R Soc Med       Date:  1968-12-12

4.  De novo malignant tumors in organ transplant recipients.

Authors:  I Penn; C G Halgrimson; T E Starzl
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

5.  Immunosurveillance and cancer: epidemiological evidence.

Authors:  R Doll; L Kinlen
Journal:  Br Med J       Date:  1970-11-14

6.  Transplanted carcinoma in an immunosuppressed patient.

Authors:  B Matter; C F Zukoski; D A Killen; E Ginn
Journal:  Transplantation       Date:  1970-01       Impact factor: 4.939

7.  Hazard of immunosuppressive therapy.

Authors:  N Manny; E Rosenman; J Benbassat
Journal:  Br Med J       Date:  1972-04-29

8.  Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis.

Authors:  J F Patterson; R A Norton; R S Schwartz
Journal:  Am J Dig Dis       Date:  1971-04

9.  Nephrotic syndrome due to primary renal disease in adults: I. Survey of incidence in South-east England.

Authors:  P Sharpstone; C S Ogg
Journal:  Br Med J       Date:  1969-05-31

10.  Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice.

Authors:  T P Casey
Journal:  Clin Exp Immunol       Date:  1968-05       Impact factor: 4.330

View more
  1 in total

1.  Upper Gastrointestinal Tract Lymphoma With Natalizumab: Evidence of Impaired Immune Surveillance?

Authors:  Lauren Gomes; Emily Watson; Matthew Robert Smith; Edward Morris; Mike Boggild
Journal:  Neurol Clin Pract       Date:  2021-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.